ADMA vs BIIB: Which Stock is Better?
Side-by-side comparison of Adma Biologics Inc and Biogen Inc in 2026
ADMA
Adma Biologics Inc
$15.39
BIIB
Biogen Inc
$184.87
Key Metrics Comparison
| Metric | ADMA | BIIB | Winner |
|---|---|---|---|
| Market Cap | $3.67B | $27.13B | BIIB |
| P/E Ratio | 25.65 | 21.42 | BIIB |
| EPS (TTM) | $0.60 | $8.63 | BIIB |
| Revenue Growth | 0.2% | -0.1% | ADMA |
| Gross Margin | 57.4% | 78.9% | BIIB |
Analyze ADMA
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADMA or BIIB a better investment?
Comparing ADMA and BIIB: Adma Biologics Inc has a market cap of $3.67B while Biogen Inc has $27.13B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADMA and BIIB?
ADMA (Adma Biologics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADMA or BIIB?
Based on P/E ratios, BIIB trades at a lower multiple (21.4x vs 25.6x).
Which is growing faster: ADMA or BIIB?
ADMA has higher revenue growth at 0.2% vs -0.1% for BIIB.
Which company is more profitable: ADMA or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 57.4% for ADMA.
Which is the larger company: ADMA or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.13B compared to $3.67B for ADMA.
Should I buy ADMA or BIIB in 2026?
Both ADMA and BIIB have investment merit. ADMA trades at $15.39 while BIIB trades at $184.87. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADMA and BIIB stock?
Key differences: Market Cap ($3.67B vs $27.13B), P/E Ratio (25.6x vs 21.4x), Revenue Growth (0.2% vs -0.1%), Gross Margin (57.4% vs 78.9%).